Related Experiment Videos
Serum lipoprotein pattern variations in dementia and ischemic stroke.
F Giubilei1, R D'Antona, R Antonini
1Department of Neurological Sciences, University of Rome, La Sapienza, Italy.
Acta Neurologica Scandinavica
|January 1, 1990
Summary
This study found higher total cholesterol and Apo-B in Alzheimer's patients and elevated Apo-B in stroke patients. Stroke patients also had the lowest HDL-cholesterol levels, indicating potential lipid-related risks for these neurological conditions.
Area of Science:
- Neuroscience
- Cardiovascular Science
- Biochemistry
Background:
- Cerebrovascular diseases and dementia are significant health concerns.
- Lipid metabolism alterations are implicated in neurological disorders.
- Understanding lipid profiles in different dementia and stroke types is crucial for risk assessment.
Purpose of the Study:
- To compare blood lipid profiles, including triglycerides, total cholesterol, lipoprotein fractions (VLDL-LDL- and HDL-cholesterol), and apoproteins (Apo-A1 and Apo-B).
- To investigate these profiles in patients with multi-infarct dementia, Alzheimer-type dementia, and ischemic stroke due to carotid atherosclerosis.
- To establish reference values using healthy control subjects.
Main Methods:
- A cohort of 40 patients was studied, with 10 patients in each of the four groups: multi-infarct dementia, Alzheimer-type dementia, ischemic stroke, and controls.
- Blood samples were analyzed for triglycerides, total cholesterol, VLDL-LDL-cholesterol, HDL-cholesterol, Apo-A1, and Apo-B levels.
Main Results:
- Alzheimer's disease patients exhibited significantly higher mean total cholesterol and Apo-B levels compared to controls.
- Ischemic stroke patients showed significantly elevated Apo-B levels relative to controls.
- Stroke patients presented with the lowest mean HDL-cholesterol (HDL-c) values.
- No significant differences in mean HDL-c levels were observed between multi-infarct dementia and Alzheimer-type dementia patients.
Conclusions:
- Elevated total cholesterol and Apo-B are associated with Alzheimer's disease.
- Increased Apo-B and decreased HDL-c are linked to ischemic stroke.
- Lipid profile variations may serve as biomarkers for differentiating or assessing risk in various neurological conditions.